Abstract:The appropriate antibiotic treatment of patients with bacterial sepsis in the intensive care unit (ICU) remains a challenge. Considering that current international guidelines recommend 7 days of antibiotic therapy as sufficient for most severe infections, our primary outcome was a comparison of clinical response to initial empirical therapy on day 7 and mortality between two groups of septic patients—with appropriate (AEAT) and inappropriate (IEAT) empirical antibiotic therapy according to the in vitro sensitivity of bacteria detected in a blood culture (BC). Adult patients admitted to the ICU between 2020 and 2023, who were diagnosed with sepsis according to the Sequential Organ Failure Assessment (SOFA) score ≥ 2 in association with a suspected or documented infection, were selected for the study. Of the 418 patients, 149 (35.6%) died within 7 days. Although the AEAT group had a lower mortality rate (30.3% vs. 34.2%) and better clinical improvement (52.8% vs. 47.4%) on day 7 after starting empirical antibiotic therapy, there was no significant difference. A causative organism was isolated from BCs in 30% of septic patients, with gram-negative bacteria (GNB) predominating in 60% of cases, and multidrug-resistant (MDR) or extensively drug-resistant (XDR) bacteria predominantly detected in the BCs of the IEAT group. Although the AEAT group had slightly worse clinical characteristics at the onset of sepsis than the IEAT group, the AEAT group showed faster improvement on days 7 and 14 of sepsis. In this retrospective cross-sectional study, the AEAT group was associated with better clinical response at day 7 after sepsis onset and lower mortality, but without a significant difference. Comorbidities and the type of bacterial pathogen should also be taken into account as they can also contribute to the prediction of the final outcome. These results demonstrate the importance of daily assessment of clinical factors to more accurately predict the clinical outcome of a septic patient.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the impact of appropriate initial empirical antibiotic treatment (AEAT) on the clinical response of septic patients in the intensive care unit (ICU), and whether this treatment is associated with a lower mortality rate. Specifically, the main objective of the study was to compare the clinical response and mortality rate on the 7th day after the start of treatment between septic patients who received appropriate initial empirical antibiotic treatment and those who received inappropriate initial empirical antibiotic treatment (IEAT). ### Research Background - **Sepsis**: Sepsis is a systemic inflammatory response caused by infection, which can lead to multiple - organ failure and high mortality in severe cases. - **Initial empirical antibiotic treatment**: Due to the urgent condition of septic patients and the unidentified pathogen, doctors usually select broad - spectrum antibiotics for initial treatment based on clinical experience and epidemiological data. - **Appropriate and inappropriate treatments**: Appropriate empirical antibiotic treatment means that the selected antibiotics are sensitive to the cultured pathogen; inappropriate treatment means that the selected antibiotics are ineffective or partially effective against the pathogen. ### Research Objectives - **Primary objective**: To compare the clinical response and mortality rate on the 7th day after the start of treatment between septic patients who received appropriate initial empirical antibiotic treatment (AEAT) and those who received inappropriate initial empirical antibiotic treatment (IEAT). - **Secondary objective**: To explore the impact of patients' underlying diseases, infection types and other factors on the clinical outcome. ### Research Methods - **Study design**: Single - center observational study. - **Study subjects**: Adult patients diagnosed with sepsis in the ICU of a hospital in Croatia between 2020 and 2023. - **Grouping criteria**: According to the blood culture results, patients were divided into the AEAT group and the IEAT group. - **Primary outcome measures**: Clinical response (improved/cured or worsened) and mortality rate on the 7th day after the start of treatment. ### Research Results - **Clinical response**: The clinical improvement rate in the AEAT group on the 7th day was 52.8%, while that in the IEAT group was 47.4%, but the difference was not statistically significant (p = 0.574). - **Mortality rate**: The 7 - day, 14 - day, 28 - day and ICU mortality rates in the AEAT group were 30.3%, 42.7%, 50.6% and 55.1% respectively, while those in the IEAT group were 34.2%, 47.4%, 60.5% and 68.4% respectively, and none of the differences were statistically significant. - **Pathogen characteristics**: In the IEAT group, more Enterobacteriaceae producing extended - spectrum β - lactamases (ESBL), carbapenem - resistant Enterobacteriaceae (CRE) and carbapenem - resistant Pseudomonas aeruginosa (CRPA) were detected. ### Discussion - **Clinical significance**: Although the clinical response and mortality rate in the AEAT group were slightly better than those in the IEAT group, these differences did not reach statistical significance. This may be related to the smaller sample size in the IEAT group. - **Prognostic factors**: Underlying diseases, infection types and other factors have an important impact on the clinical outcome of patients, so these factors should be comprehensively considered when evaluating the clinical response. - **Future research directions**: Studies with larger sample sizes are needed to further verify these findings and explore more potential prognostic factors. Through this study, the author emphasizes the importance of daily assessment of clinical factors in order to more accurately predict the clinical outcome of septic patients.

Impact of Appropriate Empirical Antibiotic Treatment on the Clinical Response of Septic Patients in Intensive Care Unit: A Single-Center Observational Study

Impact of Pharmacist Antimicrobial Dosing Adjustments in Septic Patients on Continuous Renal Replacement Therapy in an Intensive Care Unit

Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy

Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study

Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort study

Study of Empiric Antibiotic Prescription Patterns and Microbiological Isolates in Hemodynamically Stable and Unstable ICU Patients With Community-Acquired Sepsis

Impact of antibiotic timing on mortality from Gram-negative bacteraemia in an English district general hospital: the importance of getting it right every time

Impact of empirical treatment recommendations of European guidelines for nosocomial pneumonia. A prospective cohort study

Antimicrobial Step-Down Therapy versus Conventional Antimicrobial Therapy in the Treatment of Patients with Sepsis

Outcomes of inadequate empiric therapy and timing of newer antibacterial therapy in hospitalized adults with culture-positive Enterobacterales and Pseudomonas aeruginosa: a multicenter analysis

Association Between Timing and Adequacy of Antibiotics and Adverse Outcomes in Patients with Sepsis and Septic Shock: A Multicentre Retrospective Cohort Study

Use of Antimicrobials for Bloodstream Infections in the Intensive Care Unit, a Clinically Oriented Review

Impact of Inappropriate Empirical Antibiotic Treatment on Clinical Outcomes of Urinary Tract Infections Caused by Escherichia Coli: a Retrospective Cohort Study.

Empirical carbapenems or piperacillin/tazobactam for infections in intensive care: An international retrospective cohort study

Sepsis and septic shock – an observational study of the incidence, management, and mortality predictors in a medical intensive care unit

Influence of Appropriate Empirical Antibiotic Treatment on the Prognosis of ICU Patients with HAP Caused by Carbapenem-Resistant Gram-Negative Bacteria.

Clinical Outcomes of Protocolized Antibiotic Dosing in Critically Ill Surgical Patients With Bacteremia and Augmented Renal Clearance Compared With Critically Ill Surgical Patients Without Augmented Renal Clearance

Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis

THE USE OF EMPIRICAL ANTIBIOTICS IN THE CRITICAL CARE UNIT

Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP

Organisms causing community-acquired bloodstream infection in medical department: A single centre retrospective observational study